Stock listing
Entia Biosciences Inc
Selected listing: ERGO · OTC · USD · US
Entia Biosciences Inc (OTC:ERGO), Health Technology. Latest release Feb 24, 2017: Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide…
- Ticker
- OTC:ERGO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD
About Entia Biosciences Inc
The company focuses on developing innovative bioscience solutions. As a publicly traded entity, it is subject to regulatory oversight and provides transparency to its investors.
Latest news from Entia Biosciences Inc
Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products Line
February 24, 2017
Entia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses
November 2, 2016
Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting
October 6, 2016
Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months
September 26, 2016
UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.
December 21, 2015
Research Entia Biosciences Inc
Entia Biosciences Inc company profile
View the public company page for Entia Biosciences Inc on 6ix.
Entia Biosciences Inc news
Read company news and market updates connected to Entia Biosciences Inc.
Entia Biosciences Inc investor events
Find investor webinars, events, and replay context for Entia Biosciences Inc.